(1) Parenteral pharmaceuticals dispensed to patients must have a permanent label with the following information:
- (a) the name and contact information of the pharmacy including a phone number which provides access to a pharmacist 24 hours per day, seven days per week;
- (b) the date the product was prepared;
- (c) the prescription identifying number;
- (d) the patient's full name;
- (e) the name of the prescribing practitioner;
- (f) the directions for use including infusion rate and infusion device, if applicable;
- (g) the name of each component, its strength, and amount;
- (h) the expiration date of the product based on published data;
- (i) the appropriate ancillary instructions such as storage instructions or cautionary statements including antineoplastic warning when applicable; and
- (j) the identity of the pharmacist compounding and dispensing the product.
Authorizing statute(s): 50-5-103, MCA
Implementing statute(s): 50-5-103, 50-5-213, MCA
History: NEW, 1996 MAR p. 2587, Eff. 10/4/96; TRANS, from DHES, 2002 MAR p. 185; AMD, 2009 MAR p. 1668, Eff. 9/25/09.